Results 51 to 60 of about 343,983 (293)

Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care [PDF]

Integrative Cancer Therapies, 2022
As medical cannabis becomes legal in more states, cancer patients are increasingly interested in the potential utility of the ancient botanical in their treatment regimen. Although eager to discuss cannabis use with their oncologist, patients often find that their provider reports that they do not have adequate information to be helpful.
openaire   +5 more sources

Innovation of plant‐derived extracellular vesicles and interdisciplinary research: From discovery to biomedical applications

BMEMat, EarlyView.
Plant‐derived extracellular vesicles offer numerous advantages and are regarded as highly promising candidates in the field of biomedicine. Abstract Extracellular vesicles (EVs) are double‐membrane vesicular structures that can be secreted by nearly all living cells.
Zilin Li, Yi Wei, Ben Hu, Yafang Song, Xiaojia Chen, Nik Ahmad Nizam Nik Malek, Tongkai Chen   +6 more
wiley   +1 more source

Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer

Trials, 2022
Background Recruitment for randomised controlled trials in palliative care can be challenging; disease progression and terminal illness underpin high rates of attrition.
Rebecca E. Olson, Alexandra Smith, Georgie Huggett, Phillip Good, Morgan Dudley, Janet Hardy   +5 more
doaj   +1 more source

(Re)introducing medicinal cannabis [PDF]

Medical Journal of Australia, 2013
• After considering extensive scientific and medical evidence, a New South Wales Legislative Council multiparty committee recommended that medicinal cannabis should lawfully be made available for selected-use pharmacotherapy. • The evidence indicates that cannabis has genuine medicinal utility in patients with certain neuropathic conditions, with ...
Laurence E, Mather, Evert R, Rauwendaal, Vivienne L, Moxham-Hall, Alex D, Wodak   +3 more
openaire   +2 more sources

Enantioseparation of chiral phytocannabinoids in medicinal cannabis

Journal of Chromatography B, 2023
The evaluation of the chiral composition of phytocannabinoids in the cannabis plant is particularly important as the pharmacological effects of the (+) and (-) enantiomers of these compounds are completely different. Chromatographic attempts to assess the presence of the minor (+) enantiomers of the main phytocannabinoids, cannabidiolic acid (CBDA) and
Russo, Fabiana, Tolomeo, Francesco, Angela Vandelli, Maria, Biagini, Giuseppe, Laganà, Aldo, Capriotti, Anna Laura, Cerrato, Andrea, Carbone, Luigi, Perrone, Elisabetta, Cavazzini, Alberto, Maiorano, Vincenzo, Gigli, Giuseppe, Cannazza, Giuseppe, Citti, Cinzia   +13 more
openaire   +4 more sources

Cannabis-based medicinal products: a clinical guide [PDF]

, 2022
Cannabis sativa L has a long history as a medicinal plant, dating back more than two millennia. Preclinical studies using both pharmacological and genetic approaches have increased the understanding of this plant and its importance in providing ...
Sodergren, Mikael H, Philips, Elisabeth, Erridge, Simon   +2 more
core   +1 more source

Industrial Symbiosis as a Neglected Opportunity in Industrial Decarbonisation Pathways: Qualitative Insights From the Australian Manufacturing Sector

Business Strategy and the Environment, EarlyView.
ABSTRACT Industrial symbiosis (IS) represents a key strategy for industrial decarbonisation (ID) by converting one industry's waste into valuable inputs for another, reducing emissions and resource extraction. Scientific studies have explored the concept, implementation approaches and theoretical foundations of IS.
Marzieh Dehghan Niri, A S M Monjurul Hasan, Andrea Trianni   +2 more
wiley   +1 more source

Cannabis and public health: a study assessing regular cannabis users through health indicators [PDF]

, 2023
Background and Objective: An increasing number of countries are deciding to regulate the medicinal and/or recreational use of cannabis (Cannabis sativa L.). However, there is a lack of information on the impact of regular consumption of this substance on
Hidalgo Jiménez, Javier, Bouso, José Carlos, Alcázar Córcoles, Miguel Ángel, Oña, Genís, Javier Hidalgo Jiménez, José Carlos Bouso, Miguel Ángel Alcázar-Córcoles, Genís Oña   +7 more
core   +1 more source

Perspectives in biomedicine: Superfoods and antioxidant power classification

The Canadian Journal of Chemical Engineering, EarlyView.
Abstract The market value of natural food antioxidants will double to 8 billion USD by 2033, driven by a global consumer demand for ‘clean label’ products and proactive wellness solutions. However, the industrial application and health labelling (commercial brands) of these compounds remain severely constrained by inconsistent analytical methods.
Domenico Fuoco, Gregory S. Patience
wiley   +1 more source

QUALIDADE DE VIDA DOS PACIENTES USUÁRIOS DE CANNABIS MEDICINAL

, 2023
INTRODUÇÃO: A cannabis medicinal recebeu maior atenção da pesquisa nos últimos anos devido ao afrouxamento de mudanças regulatórias globais. A cannabis medicinal tem eficácia potencial na redução da dor, espasticidade muscular, náuseas e vômitos ...
Ane Kássia de Carvalho Barbosa, José Lopes Pereira Júnior, Hildnel Rodrigues Leal Silva, Thyago Layron Sampaio de Abreu   +3 more
core   +1 more source